Author:
Ludwig Heinz,Österborg Anders
Reference51 articles.
1. Kyle RA, Beard CM, O’Fallon WM, Kurland LT. Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945. J Clin Oncol 1994; 12:1577–1583.
2. Medical Research Council’s Working Party on Leukaemia in Adults. Prognostic features in the third MRC myelomatosis trial. Medical Research Council’s Working Party on Leukaemia in Adults. Br J Cancer 1980; 42:831–840.
3. Ludwig H, Barrett-Lee P, Birgegard G, et al. The European Cancer Anaemia Survey (ECAS): The first large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. Submitted for publication.
4. Musto P. The role of recombinant erythropoietin for the treatment of anemia in multiple myeloma. Leuk Lymphoma 1998; 29:283–291.
5. Beguin Y, Yerna M, Loo M, Weber M, Fillet G. Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. Br J Haematol 1992; 82:648–653.